177 related articles for article (PubMed ID: 36869855)
1. Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30-year cohort study.
Hakeem H; Alsfouk BAA; Kwan P; Brodie MJ; Chen Z
Epilepsia; 2023 May; 64(5):1248-1258. PubMed ID: 36869855
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and treatment outcomes of newly diagnosed epilepsy in older people: A 30-year longitudinal cohort study.
Alsfouk BAA; Hakeem H; Chen Z; Walters M; Brodie MJ; Kwan P
Epilepsia; 2020 Dec; 61(12):2720-2728. PubMed ID: 33098099
[TBL] [Abstract][Full Text] [Related]
3. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.
Chen Z; Brodie MJ; Liew D; Kwan P
JAMA Neurol; 2018 Mar; 75(3):279-286. PubMed ID: 29279892
[TBL] [Abstract][Full Text] [Related]
4. Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy.
Hersi H; Saarinen JT; Raitanen J; Peltola J
Front Neurol; 2022; 13():1042168. PubMed ID: 36438960
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy.
Alsfouk BAA; Brodie MJ; Walters M; Kwan P; Chen Z
JAMA Neurol; 2020 May; 77(5):574-581. PubMed ID: 32091535
[TBL] [Abstract][Full Text] [Related]
6. Does Adjustment of Antiseizure Medication Regimen after Failed Epilepsy Surgery Improve Outcomes?
Wu Y; Zhang Z; Liang P; Li L; Zou B; Wang D; Dong X; Tang H; Qiu H; Zhai X
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109743
[No Abstract] [Full Text] [Related]
7. Antiseizure medication treatment outcomes in new-onset pediatric epilepsy.
Itamura S; Sasaki K; Fujii Y; Okano R
Pediatr Int; 2023; 65(1):e15523. PubMed ID: 36912459
[TBL] [Abstract][Full Text] [Related]
8. Markov modelling of treatment response in a 30-year cohort study of newly diagnosed epilepsy.
Simpson HD; Foster E; Ademi Z; Lawn N; Brodie MJ; Chen Z; Kwan P
Brain; 2022 May; 145(4):1326-1337. PubMed ID: 34694369
[TBL] [Abstract][Full Text] [Related]
9. Trends in Antiseizure Medication Initiation, Switch, or Termination in Patients With Newly Diagnosed Epilepsy: A Nationwide Study.
Bolin K; Patric B; Tomson T
Neurology; 2024 Jul; 103(2):e209500. PubMed ID: 38870473
[TBL] [Abstract][Full Text] [Related]
10. Second antiseizure medication monotherapy in patients with adult-onset epilepsy: A register-based analysis.
Polychronidis K; Håkansson S; Hosseini Ashtiani S; Idegård A; Larsson D; Zelano J
Epilepsy Behav; 2024 Jun; 155():109792. PubMed ID: 38669974
[TBL] [Abstract][Full Text] [Related]
11. Non-discontinuation of antiseizure medication in seizure-free epilepsy patients.
Doerrfuss JI; Hüsing T; Graf L; Ilyas-Feldmann M; Holtkamp M
Eur J Neurol; 2024 Mar; 31(3):e16160. PubMed ID: 38015451
[TBL] [Abstract][Full Text] [Related]
12. Prescribed antiseizure medication doses and their relation to defined daily doses for achieving seizure freedom in newly diagnosed patients with epilepsy.
Hersi H; Raitanen J; Saarinen JT; Peltola J
Epilepsia Open; 2023 Sep; 8(3):811-819. PubMed ID: 37010264
[TBL] [Abstract][Full Text] [Related]
13. Anti-seizure medications for Lennox-Gastaut syndrome.
Brigo F; Jones K; Eltze C; Matricardi S
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230
[TBL] [Abstract][Full Text] [Related]
14. Clinical factors associated with late seizure remission after failed epilepsy surgery.
Kaye LC; Poolos ZA; Miller JW; Poolos NP
Epilepsy Behav; 2023 Jan; 138():109055. PubMed ID: 36543042
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of one-year effectiveness of clobazam as an add-on therapy to anticonvulsant monotherapy in participants with epilepsy having uncontrolled seizure episodes: An Indian experience.
Satishchandra P; Rathore C; Apte A; Kumar A; Mandal A; Chauhan D; Agadi J; Gurumukhani J; Asokan K; Venkateshwarlu K; Lingappa L; Sundaracharya NV; Jha SK; Ravat S; Vk S; Garg S; Shah SV; Alagesan S; Razdan S; Padhy U; Agarwal VK; Arora V; Menon B; Shetty S; Chodankar D
Epilepsy Behav; 2022 May; 130():108671. PubMed ID: 35381495
[TBL] [Abstract][Full Text] [Related]
16. Clonazepam monotherapy for treating people with newly diagnosed epilepsy.
Brigo F; Igwe SC; Bragazzi NL; Lattanzi S
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013028. PubMed ID: 35187637
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure.
Fairclough S; Goodden J; Chumas P; Mathew R; Maguire M
Epilepsia; 2023 Apr; 64(4):857-865. PubMed ID: 36636895
[TBL] [Abstract][Full Text] [Related]
18. Clonazepam monotherapy for treating people with newly diagnosed epilepsy.
Brigo F; Igwe SC; Bragazzi NL; Lattanzi S
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742671
[TBL] [Abstract][Full Text] [Related]
19. Seizure control in mono- and combination therapy in a cohort of patients with Idiopathic Generalized Epilepsy.
Pipek LZ; Pipek HZ; Castro LHM
Sci Rep; 2022 Jul; 12(1):12350. PubMed ID: 35854146
[TBL] [Abstract][Full Text] [Related]
20. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
